Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$914.37 8.99 (0.99%) as of 4:30 Mon 7/1


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 874.67(B)
Last Volume: 2,545,641 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 57 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Rice Derica W EVP-Global Services and CFO   •       –      –    2014-09-04 4 OE $55.65 $1,284,235 D/D 23,077 48,077     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-09-03 4 S $63.99 $12,798,000 D/D (200,000) 133,140,804     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2014-09-02 4 AS $63.60 $318,000 D/D (5,000) 82,736     -
   Alvarez Ralph Director   –       •      –    2014-08-29 4 A $61.35 $8,589 D/D 140 23,556     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2014-08-26 4 D $62.73 $489,859 D/D (7,809) 44,308     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2014-08-26 4 OE $55.65 $468,342 D/D 8,380 47,824     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2014-08-22 4 GA $0.00 $0 D/D 25,000 25,000     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2014-08-22 4 GD $0.00 $0 I/I 25,000 251,514     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2014-08-13 4 D $60.88 $474,194 D/D (7,789) 53,530     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2014-08-13 4 OE $55.65 $474,194 D/D 8,521 61,319     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2014-08-12 4 D $61.08 $151,601 D/D (2,482) 31,052     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2014-08-12 4 OE $55.65 $151,479 D/D 2,722 32,293     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2014-08-07 4 GD $0.00 $0 I/I 470 50,046     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2014-08-07 4 GD $0.00 $0 D/D 470 533,496     -
   Alvarez Ralph Director   –       •      –    2014-07-31 4 A $63.64 $8,591 D/D 135 23,416     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-07-29 4 S $63.03 $15,757,683 D/D (250,000) 133,340,804     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2014-07-28 4 S $63.30 $130,715 I/I (2,065) 7,810     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2014-07-28 4 OE $0.00 $0 I/I 2,240 9,875     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2014-07-25 4 S $63.79 $637,900 D/D (10,000) 87,736     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2014-07-25 4 S $63.90 $1,917,000 D/D (30,000) 52,798     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-07-01 4 S $62.30 $14,640,500 D/D (235,000) 133,590,804     -
   Alvarez Ralph Director   –       •      –    2014-06-30 4 A $58.83 $8,589 D/D 146 23,281     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-06-25 4 S $62.68 $15,356,768 D/D (245,000) 133,825,804     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-06-20 4 S $61.31 $14,156,084 D/D (230,000) 134,070,804     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-06-16 4 S $58.73 $11,746,000 D/D (200,000) 134,300,804     -
  1436 Records found
  Previous  50  51  52  53  54  55  56  57  58   
  Page 57 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us